1. Prognostic and Predictive Biomarkers in Patients with Locally Advanced Rectal Cancer (LARC) Treated with Preoperative Chemoradiotherapy
   Alfonso Martín-Carnicero et al, 2022, Journal of Clinical Medicine CrossRef
2. A study of pre- and post-treatment hematologic markers of immune response in patients undergoing radiotherapy for soft tissue sarcoma
   Eric Ku et al, 2024, Frontiers in Oncology CrossRef
3. Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy
   Nebojsa Manojlovic et al, 2022, World Journal of Clinical Cases CrossRef
4. High Neutrophil-To-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer
   Nándor Polk et al, 2022, Pathology and Oncology Research CrossRef
5. Prognostic significance of albumin to alkaline phosphatase ratio in critically ill patients with acute kidney injury
   Wenkai Xia et al, 2022, Clinical and Experimental Nephrology CrossRef
6. Association of baseline neutrophil-to-lymphocyte ratio and prognosis in melanoma patients treated with PD-1/PD-L1 blockade: a systematic review and meta-analysis
   Michele Kreuz et al, 2024, Melanoma Research CrossRef
7. PLAG co-treatment increases the anticancer effect of Adriamycin and cyclophosphamide in a triple-negative breast cancer xenograft mouse model
   Guen Tae Kim et al, 2022, Biochemical and Biophysical Research Communications CrossRef
8. Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer
   Zoltan Herold et al, 2022, World Journal of Clinical Cases CrossRef
9. Prognostic biomarkers in metastatic colorectal cancer: delta prognostic nutritional index, delta neutrophil to lymphocyte ratio, and delta platelet to lymphocyte ratio
   Mehmet Zahid Kocak et al, 2023, Supportive Care in Cancer CrossRef
10. Role of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Predicting the Response to First Line Chemotherapy in Colorectal Cancer Patients with Synchronous Liver Metastases: A Retrospective Study
    Nima Mousavi Darzikolaee et al, 2021, International Journal of Cancer Management CrossRef
11. The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review
    Kian Heshmat-Ghahdarijani et al, 2023, Frontiers in Oncology CrossRef
12. Systemic and local immunosuppression in glioblastoma and its prognostic significance
    Aleksei A. Stepanenko et al, 2024, Frontiers in Immunology CrossRef
13. Neutrophil-Lymphocyte Ratio (NLR) as a Prognostic Marker in Advanced Lung Cancer Patients Undergoing First-Line Treatment
    Dinda Ary Miranda Dewi et al, 2024, Jurnal Respirasi CrossRef
14. Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators—a review
    Alexandra-Ligia Dinca et al, 2023, International Journal of Immunopathology and Pharmacology CrossRef
15. Gustave Roussy Immune Score (GRIm-Score) as a Prognostic and Predictive Score in Metastatic Colorectal Cancer
    Horia Cotan et al, 2024, Cureus CrossRef
16. Prognostic Significance of Systemic Inflammation Indices by K-ras Status in Patients With Metastatic Colorectal Cancer
    Yuji Miyamoto et al, 2023, Diseases of the Colon & Rectum CrossRef